Elfi-Tech Ltd. raises $2M in funding
(Rehovot-ISRAEL, 27th of December 2020) – Elfi-Tech Ltd. is excited to announce that we have successfully raised $2M funds from Toto Ltd., which is the world’s largest toilet manufacturer. The funds will be used to support a collaborative program of the two companies as well as the launching of a new product for home-care self-monitoring.
The new investment round will enable Elfi-Tech to further capitalize on its unique capabilities to measure non-invasively blood flow and related parameters for the home-care market, and deepen the relationships between Toto and Elfi-Tech. New product introduction for the self-monitoring of cardiovascular and respiratory patients is a key milestone for Elfi-Tech. The funding will also allow reaching regulation certification.
Dr. Ilya Fine, the founder and CEO said: “We highly appreciate the very fact of Toto’s investment, not only because it is the highest mark of acknowledgement of our technology, but also because the opportunity to take part in the Toto’s pioneering project. The unique combination of an innovative approach of Toto with the latest advances in non-invasive physiological measurements of Elfi-Tech, will change the personalized health management. Toto’s investment will also help to achieve our main goal – creating a platform for seamless home self-monitoring of health status. There is a clear synergy between us. We look forward that together with our partner we will contribute to the much-needed revolution in personalized home health management. “
About Elfi-Tech Ltd.
Elfi-Tech Ltd. was set up in Rehovot-ISRAEL in 2006 and is owned privately. The company develops remote non-invasive medical device technology including a proprietary laser-based sensing platform that enables users to “see” blood as it flows in the body, online. The company has developed a remote monitoring health center device, small, easy to use, multi-parametric, for home use and isolation situations, providing accurate cardiovascular parameters to the patients and to the health-care providers and organizations. The device records absolute blood pressure at the finger root, HR, SpO2, ECG, HRV and blood flow related parameters.
Important breakthrough in non-invasive COVID19 infection monitoring
A non-invasive marker for COVID19 infection was developed based on a proprietary optical sensor of Elfi-Tech.
By analyzing the optical pattern of the signal related to the Red Blood Cells (RBC) motion during stasis, the severity of the COVID19 infection is evaluated. The sensor is attached to the finger and the test lasts 2 minutes. New non-invasive marker can be used for the monitoring of infected subjects at the hospital and home environment. It could be used for real time screening. The company has performed a feasibility test demonstrating the capability to detect COVID19 infection. The company plans to run intensive clinical trials in a hospital environment and looks for partnership.
Elfi-Tech has been awarded the “H2020 Seal of Excellence” from the European Commission following the high score evaluation for the project “A mobile health platform to determine cardiovascular and health conditions”.
Elfi-Tech is inviting you to visit us at the Compamed 2019 trade fair in Dusseldorf, 18-21 November 2019, Hall 8B, stand L33
Elfi-Tech participated to the Digital Health Technologies Business Mission to Tokyo & Kobe in Japan July 1st-3rd, 2019. This event was organized by the Israel Export Institute and the Israel Ministry of Economy and Industry with the participation of many Japanese companies.
Elfi-Tech is proud to announce the publication of the paper “What do you know about Elfi-Tech and their Finger Port device?” in the journal Health Europa dated 31st of January 2019, the paper can be reached with the link:
Elfi-Tech received the ISO 13485:2016 certification. ISO 13485:2016 specifies requirements for a quality management system where an organization needs to demonstrate its ability to provide medical devices and related services that consistently meet customer and applicable regulatory requirements.
Elfi-Tech is happy to announce that a licensing agreement was signed in the framework of an Employee Safety Project for the Japanese construction industry between Murata Manufacturing Co., Ltd. a leading Japanese electronics manufacturer and Elfi-Tech. Elfi-Tech’s system shall be integrated to a protection helmet used by employees at construction sites transmitting real-time vital signs to mitigate employee safety and health risks.
Both parties are excited at the opportunity to utilize cutting-edge technologies to create safer working environments for the benefit of employees worldwide.
In an recently published article, mDLS was used to non-invasively monitor fitness levels, as it was used on three groups of subjects from 15- to 25 years of age, as they were tested prior to and after the performance of physical load. As a marker of cardiovascular fitness, we used the post-load decay rate of mDLS’ unique hemodynamic indexes (HI) and found their response to the physical load to provide a statistically significant correlation with the post-load heart rate decay. It was also found that post-occlusion increase of the arterial HI is more prominent in the group with higher physical activity. These results indicate that HI can be used as an additional marker for cardiovascular fitness level.
Join us at CES 2018 in Las Vegas (January 9-12) where we will be presetting our Finger-Port for the first time. Contact us at firstname.lastname@example.org for more information and to schedule a meeting and demo.
Elfi-Tech will be attending MIXiii Biomed 2017 National Life Science & Technology week in Tel Aviv. Please contact us for a meeting at email@example.com, and view these slides to learn more on our mDLS sensor and relevant medical & digital health applications.
In an article recently published in the latest issue of SPIE journal, mDLS was used to non-invasively monitor stress levels, by using a new concept of oscillatory hemodynamic indexes. In addition, the article examines the capability of using this new stress index for the individual monitoring of the diurnal stress level, and it was demonstrated that this new marker provides good sensitivity and specificity to the stress response to sound and musical emotional arousal.
Excited to provide our forehead product to the US SOCOM (‘H92222-15-C-0074’) to monitor a set of unique vital signs during training. In addition to motion sensors, this device has a pulse-oximeter sensor for SPO2 and heart rate, in addition to mDLS, for our advanced hemodynamic parameters and blood flow.
Elfi-Tech is proud to present its Data-Logger – The first mDLS wearable device. The Data-Logger is the perfect testbed for the collection of physiological data and vital signs monitoring. The Data-Logger records from multiple sensors, such as PPG and mDLS, and allows maximum convenience and flexibility due to its battery capabilities, allowing 12 hours of nonstop recordings and up to 24 hours in certain settings. The Data-Logger is optimized as a wrist device, but due to mDLS’s unique features, can be utilized for other locations on the body as well.
As demonstrated in an article recently published in Surgical Innovation (Surgical Innovation, Dec. 2015 – please contact us for the article), the Elfi-Tech mDLS monitor can assess gastrointestinal anastomotic healing and predict leakage at the surgical site. By its ability to measure the microcirculation, the Elfi-Tech mDLS monitor can be used to measure the peripheral blood circulation in other surgical applications, such as plastic surgery skin flaps and in the assessment of blood flow in ischemic limbs before and after revascularization.
Elfi-Tech is proud to participate in the Consumer Electronics Show (CES) showcasing its latest technology – Elfi-Tech’s advanced reference design PPG wrist device, measuring accurate heart rate in motion together with continuous HRV. Elfi-Tech also showcased its proprietary mDLS sensing platform that measures additional parameters such as skin blood flow, blood velocity, relative blood pressure, coagulation, vascular health and fitness assessment applications.